Biond Biologics Appoints Giovanni Selvaggi, M.D., as Chief Medical Officer ("CMO")
Dr. Selvaggi, a veteran immuno-oncology executive brings more than 30 years of oncology experience and a proven track record of advancing global clinical programs, with novel cancer therapies to registration, strengthening Biond's efforts to advance the clinical development of BND-67 and...
Dr. Selvaggi, a veteran immuno-oncology executive brings more than 30 years of oncology experience and a proven track record of advancing global clinical programs, with novel cancer therapies to registration, strengthening Biond's efforts to advance the clinical development of BND-67 and...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.